hotspot -WSS

hotspot

author：explore 2025-10-02 04:08:17 - browse：997

A psilocybin mushroom lays inside a clear capsule — Adobe

A single dose of psilocybin may have enduring benefits for people with major depressive disorder, according to a randomized clinical trial published Thursday in the Journal of the American Medical Association.

Several prior studies have suggested that psilocybin, the psychedelic compound produced by certain types of mushrooms, could be a promising way to treat major depression in people for whom antidepressants or counseling aren’t effective. But those studies mostly focused on short-term results, while the new JAMA study looked at psilocybin’s efficacy up to six weeks after the administration of a single dose of psilocybin.

“It’s exciting to see another study that’s coming out that is adding to the evidence base suggesting potential efficacy of psilocybin for depression, amongst other conditions,” said Greg Fonzo, an assistant professor and co-director for the Center for Psychedelic Research and Therapy at the University of Texas at Austin’s Dell Medical School, who was not involved in the study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

WSS

Nick Jonas talks about managing diabetes along with his career

A timeline of the missing Titanic tourist submersible

EU climate chief is concerned over the expansion of the coal industry in China

4 dead, 2 in stable condition in Philadelphia shooting: Police

Peter Marks talks Operation Warp Speed for Rare Diseases

EU climate chief is concerned over the expansion of the coal industry in China

hotspot

hotspot

focus

Duchenne breakthrough therapy leaves behind pioneering families

Wellcome Trust names Røttingen as its new CEO

Medicare details structure of new drug price negotiation program

Female surgeons have lower rates of long

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Leon Gautier, last member of French D

Bright Health sells Medicare Advantage business to Molina

Wellcome Trust names Røttingen as its new CEO

Alkermes shareholders re

How should state employee insurance handle Wegovy?

hotspot

Some in Scotland's Orkney Islands want to return to Norway after 550 years

STAT Readout Newsletter: Today in biotech, life science news

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Bernie Sanders bashes nonprofit hospitals over their tax breaks

European regulators consider appeal over Amylyx ALS drug

focus

entertainment

hotspot

Wikipedia